Actively Recruiting
Two Electroacupuncture Waveforms for Different Severity Groups of Bell Palsy
Led by The Third Affiliated hospital of Zhejiang Chinese Medical University · Updated on 2024-10-21
120
Participants Needed
3
Research Sites
111 weeks
Total Duration
On this page
Sponsors
T
The Third Affiliated hospital of Zhejiang Chinese Medical University
Lead Sponsor
T
The First Affiliated Hospital of Zhejiang Chinese Medical University
Collaborating Sponsor
AI-Summary
What this Trial Is About
Bell palsy (BP) is the most common cause of acute facial palsy, which leads to functional and esthetic disturbances for patients and results in a lowered quality of life. Electroacupuncture (EA) received attention as an alternative and complementary treatment method. The low-frequency continuous wave EA and the intermittent wave EA have been used in the management of BP. The aim of this study is to compare the efficacy and safety of these two electroacupuncture waveforms for different severity groups of BP.
CONDITIONS
Official Title
Two Electroacupuncture Waveforms for Different Severity Groups of Bell Palsy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with Bell palsy by a specialist
- Facial Nerve Grading System 2.0 score of 15 or higher on day 21 after Bell palsy onset
- Age between 18 and 65 years
- Treated with prednisolone within 72 hours of Bell palsy symptoms, starting with 60 mg per day for 5 days, then reduced by 10 mg per day
- Signed informed consent and agreed to participate in the study
You will not qualify if you...
- Facial palsy due to other diseases or injury
- Diagnosis of Ramsey-Hunt syndrome
- Bilateral facial palsy
- History of previous facial palsy
- Presence of facial spasm, synkinesis, or contracture on day 21 after Bell palsy onset
- History of facial surgery
- Uncontrolled diabetes, hypertension, serious heart, liver, or kidney damage, cognitive impairment, aphasia, or mental disorders
- Having a pacemaker installed
- Pregnant or breastfeeding
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
The First Affiliated Hospital of Zhejiang Chinese Medical University
Hangzhou, Zhejiang, China, 310006
Actively Recruiting
2
The Third Affiliated hospital of Zhejiang Chinese Medical University
Hangzhou, Zhejiang, China, 310053
Actively Recruiting
3
Hangzhou First People' s Hospital, Hangzhou
Hangzhou, Zhejing, China, 310006
Actively Recruiting
Research Team
J
Jing Sun, MD, Ph.D
CONTACT
Z
Zhiyuan Bian
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here